142 related articles for article (PubMed ID: 9126998)
1. Potent anti-feline immunodeficiency virus and anti-human immunodeficiency virus effect of IFN-tau.
Pontzer CH; Yamamoto JK; Bazer FW; Ott TL; Johnson HM
J Immunol; 1997 May; 158(9):4351-7. PubMed ID: 9126998
[TBL] [Abstract][Full Text] [Related]
2. Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-gamma.
Tanabe T; Yamamoto JK
J Interferon Cytokine Res; 2001 Dec; 21(12):1039-46. PubMed ID: 11798461
[TBL] [Abstract][Full Text] [Related]
3. Follow-Up of Viral Parameters in FeLV- or FIV-Naturally Infected Cats Treated Orally with Low Doses of Human Interferon Alpha.
Gomez-Lucia E; Collado VM; Miró G; Martín S; Benítez L; Doménech A
Viruses; 2019 Sep; 11(9):. PubMed ID: 31514435
[TBL] [Abstract][Full Text] [Related]
4. Anti-HIV potential of a new interferon, interferon-tau (trophoblastin).
Dereuddre-Bosquet N; Clayette P; Martin M; Mabondzo A; Frétier P; Gras G; Martal J; Dormont D
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Mar; 11(3):241-6. PubMed ID: 8603260
[TBL] [Abstract][Full Text] [Related]
5. Interferon-tau: current applications and potential in antiviral therapy.
Chon TW; Bixler S
J Interferon Cytokine Res; 2010 Jul; 30(7):477-85. PubMed ID: 20626290
[TBL] [Abstract][Full Text] [Related]
6. [Anti-HIV effects of IFN-tau in human macrophages: role of cellular antiviral factors and interleukin-6].
Maneglier B; Rogez-Kreuz C; Dereuddre-Bosquet N; Martal J; Devillier P; Dormont D; Clayette P
Pathol Biol (Paris); 2008; 56(7-8):492-503. PubMed ID: 18842358
[TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant interferon-tau on ovine lentivirus replication.
Juste RA; Ott TL; Kwang J; Bazer FW; de la Concha-Bermejillo A
J Interferon Cytokine Res; 1996 Dec; 16(12):989-94. PubMed ID: 8973999
[TBL] [Abstract][Full Text] [Related]
8. Involvement of IL-6 in the anti-human immunodeficiency virus activity of IFN-tau in human macrophages.
Rogez-Kreuz C; Manéglier B; Martin M; Dereuddre-Bosquet N; Martal J; Dormont D; Clayette P
Int Immunol; 2005 Aug; 17(8):1047-57. PubMed ID: 15976033
[TBL] [Abstract][Full Text] [Related]
9. A potential live vector, foamy virus, directed intra-cellular expression of ovine interferon-tau exhibited the resistance to HIV infection.
Fujii Y; Murase Y; Otake K; Yokota Y; Omoto S; Hayashi H; Okada H; Okada N; Kawai M; Okuyama H; Imakawa K
J Vet Med Sci; 2004 Feb; 66(2):115-21. PubMed ID: 15031537
[TBL] [Abstract][Full Text] [Related]
10. [Feline immunodeficiency virus infection: interferon gamma secretion in a T-lymphoblastoid infected cell line].
Mórtola EC; Endo Y; Zuccolilli GO; Gimeno EJ
Rev Argent Microbiol; 1999; 31(3):127-34. PubMed ID: 10509391
[TBL] [Abstract][Full Text] [Related]
11. [IFN-tau, a new interferon type I with antiretroviral activity].
Clayette P; Martin M; Dereuddre-Bosquet N; Tournay V; Gras G; Martal J; Dormont D
Pathol Biol (Paris); 1999 May; 47(5):553-9. PubMed ID: 10418039
[TBL] [Abstract][Full Text] [Related]
12. Derivatives of 4-amino-3,6-disulfonato-1,8-naphthalimide inhibit reverse transcriptase and suppress human and feline immunodeficiency virus expression in cultured cells.
Rideout D; Schinazi R; Pauza CD; Lovelace K; Chiang LC; Calogeropoulou T; McCarthy M; Elder JH
J Cell Biochem; 1993 Apr; 51(4):446-57. PubMed ID: 7684385
[TBL] [Abstract][Full Text] [Related]
13. C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.
Medinas RJ; Lambert DM; Tompkins WA
J Virol; 2002 Sep; 76(18):9079-86. PubMed ID: 12186891
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.
Auwerx J; Esnouf R; De Clercq E; Balzarini J
Mol Pharmacol; 2004 Jan; 65(1):244-51. PubMed ID: 14722257
[TBL] [Abstract][Full Text] [Related]
15. Anti-human immunodeficiency virus (HIV) agents are also potent and selective inhibitors of feline immunodeficiency virus (FIV)-induced cytopathic effect: development of a new method for screening of anti-FIV substances in vitro.
Tanabe-Tochikura A; Tochikura TS; Blakeslee JR; Olsen RG; Mathes LE
Antiviral Res; 1992 Aug; 19(2):161-72. PubMed ID: 1332602
[TBL] [Abstract][Full Text] [Related]
16. Evolutionarily conserved epitopes on human immunodeficiency virus type 1 (HIV-1) and feline immunodeficiency virus reverse transcriptases detected by HIV-1-infected subjects.
Sanou MP; Roff SR; Mennella A; Sleasman JW; Rathore MH; Yamamoto JK; Levy JA
J Virol; 2013 Sep; 87(18):10004-15. PubMed ID: 23824804
[TBL] [Abstract][Full Text] [Related]
17. Anti-human immunodeficiency virus activity of tau interferon in human macrophages: involvement of cellular factors and beta-chemokines.
Rogez C; Martin M; Dereuddre-Bosquet N; Martal J; Dormont D; Clayette P
J Virol; 2003 Dec; 77(23):12914-20. PubMed ID: 14610214
[TBL] [Abstract][Full Text] [Related]
18. Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.
Dean GA; LaVoy A; Burkhard MJ
Vet Immunol Immunopathol; 2004 Jul; 100(1-2):49-59. PubMed ID: 15182995
[TBL] [Abstract][Full Text] [Related]
19. Localization of an antiviral site on the pregnancy recognition hormone, ovine trophoblast protein 1.
Pontzer CH; Ott TL; Bazer FW; Johnson HM
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5945-9. PubMed ID: 2165611
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory RNA ligand to reverse transcriptase from feline immunodeficiency virus.
Chen H; McBroom DG; Zhu YQ; Gold L; North TW
Biochemistry; 1996 May; 35(21):6923-30. PubMed ID: 8639644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
